These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9090711)

  • 21. Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma.
    Kleerup EC; Tashkin DP; Cline AC; Ekholm BP
    Chest; 1996 Mar; 109(3):702-7. PubMed ID: 8617079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining a positive expiratory pressure device with a metered-dose inhaler reservoir system using chlorofluorocarbon albuterol and hydrofluoroalkane albuterol: effect on dose and particle size distributions.
    Rau JL; Torniainen M
    Respir Care; 2000 Mar; 45(3):320-6. PubMed ID: 10771801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proventil HFA provides protection from exercise-induced bronchoconstriction comparable to proventil and ventolin.
    Dockhorn RJ; Wagner DE; Burgess GL; Hafner KB; Letourneau K; Colice GL; Klinger NM
    Ann Allergy Asthma Immunol; 1997 Jul; 79(1):85-8. PubMed ID: 9236507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and performance of a new hydrofluoroalkane (HFA 134a)-based metered dose inhaler (MDI) of salmeterol.
    Peyron ID; Britto IL; Benissan LB; Tardieu BZ
    Respir Med; 2005 Apr; 99 Suppl A():S20-30. PubMed ID: 15777605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of reducing the fine-particle mass of salmeterol from metered-dose inhalers on bronchodilatation and bronchoprotection against methacholine challenge: a randomized, placebo-controlled, double-blind, crossover study.
    Langley SJ; Allen D; McDonnell B; Wheeler N; Sharma RK; Sykes A; Woodcock A
    Clin Ther; 2005 Jul; 27(7):1004-12. PubMed ID: 16154479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of therapeutically equivalent alternatives to short acting beta(2) adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers.
    Hughes DA; Woodcock A; Walley T
    Thorax; 1999 Dec; 54(12):1087-92. PubMed ID: 10567628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting the efficiency of aerosol therapy with pressurised metered-dose inhalers through plastic spacers.
    Chuffart AA; Sennhauser FH; Wildhaber JH;
    Swiss Med Wkly; 2001 Jan; 131(1-2):14-8. PubMed ID: 11205181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone.
    Leach CL; Davidson PJ; Boudreau RJ
    Eur Respir J; 1998 Dec; 12(6):1346-53. PubMed ID: 9877489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fenoterol hydrobromide delivered via HFA-MDI or CFC-MDI in patients with asthma: a safety and efficacy comparison.
    Goldberg J; Böhning W; Schmidt P; Freund E
    Respir Med; 2000 Oct; 94(10):948-53. PubMed ID: 11059947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Systemic exposure to fluticasone propionate administered via metered-dose inhaler containing chlorofluorocarbon or hydrofluoroalkane propellant.
    Mackie AE; McDowall JE; Ventresca P; Bye A; Falcoz C; Daley-Yates PT
    Clin Pharmacokinet; 2000; 39 Suppl 1():17-22. PubMed ID: 11140429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical efficacy and safety of fluticasone propionate 1 mg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with severe asthma. U.K. study group.
    Ayres JG; Millar AB; Sykes AP
    Respir Med; 2000 Jun; 94 Suppl B():S42-50. PubMed ID: 10919685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Albuterol delivery in a neonatal ventilated lung model: Nebulization versus chlorofluorocarbon- and hydrofluoroalkane-pressurized metered dose inhalers.
    Lugo RA; Kenney JK; Keenan J; Salyer JW; Ballard J; Ward RM
    Pediatr Pulmonol; 2001 Mar; 31(3):247-54. PubMed ID: 11276138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlorofluorocarbon-free inhalation devices in asthma: are there clinical implications?
    Ruffin RE; Southcott AM
    BioDrugs; 1998 Aug; 10(2):91-6. PubMed ID: 18020587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparable bronchodilation with hydrofluoroalkane-134a (HFA) albuterol and chlorofluorocarbons-11/12 (CFC) albuterol in children with asthma.
    Shapiro GS; Klinger NM; Ekholm BP; Colice GL
    J Asthma; 2000 Dec; 37(8):667-75. PubMed ID: 11192231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma.
    Lumry W; Noveck R; Weinstein S; Barnhart F; Vandermeer A; Murray A; Reisner C
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):297-303. PubMed ID: 11289328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Salmeterol HFA is as effective as salmeterol CFC in children and adults with persistent asthma.
    Chopra N; Williams M; Rimmer M; Kahl L; Jenkins M;
    Respir Med; 2005 Apr; 99 Suppl A():S1-S10. PubMed ID: 15777603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of chlorofluorocarbon and hydrofluoroalkane metered-dose inhaler formulations of beclomethasone dipropionate.
    Lipworth BJ; Jackson CM
    Br J Clin Pharmacol; 1999 Dec; 48(6):866-8. PubMed ID: 10594492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
    Tonnel AB; Bons J; Legendre M; Prud'Homme A; Bugnas B; Evano-Celli I; Stuart AM
    Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in metered dose inhaler technology with the development of a chlorofluorocarbon-free drug delivery system.
    Ross DL; Gabrio BJ
    J Aerosol Med; 1999; 12(3):151-60. PubMed ID: 10623331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.